TWO SIGMA INVESTMENTS, LP - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 120 filers reported holding ANIKA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$328,149
-80.4%
17,614
-72.7%
0.00%
-75.0%
Q2 2023$1,677,009
+20.6%
64,550
+33.4%
0.00%0.0%
Q1 2023$1,390,192
-25.0%
48,405
-22.7%
0.00%
-33.3%
Q4 2022$1,853,907
+137.7%
62,632
+91.2%
0.01%
+100.0%
Q3 2022$780,000
-46.5%
32,753
-49.9%
0.00%
-40.0%
Q2 2022$1,459,000
+20.4%
65,366
+35.4%
0.01%
+25.0%
Q1 2022$1,212,000
-36.9%
48,277
-10.0%
0.00%0.0%
Q4 2021$1,922,000
-31.1%
53,655
-18.2%
0.00%
-33.3%
Q3 2021$2,791,000
-44.4%
65,568
-43.4%
0.01%
-45.5%
Q2 2021$5,018,000
+9.1%
115,925
+2.8%
0.01%
-8.3%
Q1 2021$4,600,000
+94.6%
112,783
+115.9%
0.01%
+71.4%
Q4 2020$2,364,000
+47.9%
52,234
+15.7%
0.01%
+16.7%
Q3 2020$1,598,000
+53.8%
45,152
+64.0%
0.01%
+20.0%
Q2 2020$1,039,000
+28.0%
27,534
-2.0%
0.01%
-28.6%
Q1 2020$812,000
+191.0%
28,082
+422.5%
0.01%
+600.0%
Q4 2019$279,000
-88.3%
5,375
-87.7%
0.00%
-87.5%
Q3 2019$2,394,000
-64.0%
43,623
-73.3%
0.01%
-63.6%
Q2 2019$6,642,000
+23.0%
163,505
-8.5%
0.02%
+22.2%
Q1 2019$5,401,000
+11.6%
178,609
+24.0%
0.02%
-5.3%
Q4 2018$4,841,000
-28.0%
144,032
-9.6%
0.02%
+5.6%
Q3 2018$6,719,000
+79.7%
159,302
+36.3%
0.02%
+63.6%
Q2 2018$3,739,000
+306.9%
116,852
+531.9%
0.01%
+266.7%
Q1 2018$919,000
+35.5%
18,493
+58.1%
0.00%
+50.0%
Q3 2017$678,000
-80.0%
11,697
-82.9%
0.00%
-83.3%
Q2 2017$3,383,000
+119.1%
68,556
+92.9%
0.01%
+140.0%
Q1 2017$1,544,000
-41.7%
35,532
-34.3%
0.01%
-50.0%
Q4 2016$2,650,000
+67.6%
54,121
+63.8%
0.01%
+66.7%
Q3 2016$1,581,000
-72.2%
33,045
-68.8%
0.01%
-75.0%
Q2 2016$5,687,000
-16.4%
105,993
-30.3%
0.02%
-25.0%
Q1 2016$6,804,000
+68.0%
152,145
+43.4%
0.03%
+68.4%
Q4 2015$4,049,000
+148.1%
106,104
+107.0%
0.02%
+137.5%
Q3 2015$1,632,000
+349.6%
51,264
+366.0%
0.01%
+300.0%
Q2 2015$363,000
+45.8%
11,000
+61.9%
0.00%
+100.0%
Q3 2014$249,000
-68.2%
6,795
-59.8%
0.00%
-75.0%
Q2 2014$784,000
+288.1%
16,912
+219.1%
0.00%
+300.0%
Q4 2013$202,000
-92.1%
5,300
-95.0%
0.00%
-93.8%
Q3 2013$2,545,000
+182.8%
106,194
+100.7%
0.02%
+166.7%
Q2 2013$900,00052,9180.01%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Trigran Investments, Inc. 1,154,183$25,761,0003.00%
CAPITAL MANAGEMENT CORP /VA 275,130$6,141,0001.52%
Kent Lake Capital LLC 98,570$2,200,0001.21%
DIKER MANAGEMENT LLC 21,835$487,0000.60%
Portolan Capital Management 235,972$5,267,0000.53%
Riverwater Partners LLC 12,466$278,0000.28%
Ranger Investment Management 139,661$3,117,0000.24%
Invenomic Capital Management LP 144,287$3,220,0000.23%
CHATHAM CAPITAL GROUP, INC. 23,787$531,0000.12%
Teton Advisors, Inc. 22,000$491,0000.10%
View complete list of ANIKA THERAPEUTICS INC shareholders